Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Buzz on the Bullboards: Early Movers in Health, Mining and Tech

By the second week of the year, people, businesses and even the stock market are back to business as usual following the holiday rush in December and ringing in the new year in early January. Discussions on our Stockhouse Bullboards are also back in the saddle, and co...
Stockhouse Editorial | January 12, 2022 |

Resonant's Cup Is Half-Empty. . .Or, Is It Half-Full?

You gotta love Resonant Inc. (RESN:NASDAQ) . It seems like every quarter the company misses earning projections, yet dangles a carrot so delicious that investors get distracted. Shorts have reason to feel good; so do the bulls. RESN is a great battleground stock where ...
Streetwise Reports | August 13, 2019 |

Atomera: When Will Revenues Start?

Atomera Inc. (ATOM:NASDAQ) reported earnings on Wednesday after the close. The numbers are rather meaningless for Atomera as they are pre-revenue. What investors are looking for is clues to when revenues will start and the likelihood that customers will adopt Atomera's...
Streetwise Reports | August 14, 2019 |

Siyata Mobile Accelerating Growth on Multiple Fronts

Expands its Global Footprint with Multiple New Contracts and a Key E-Commerce Distribution Agreement and Launches Innovative New Product Focusing on one specific niche market has long been a proven path to success. It’s also a potential road to failure if y...
Featured Submission | September 29, 2021 |

Adrian Day: Adversity Often Presents Opportunities

Loews Corp. (L:NYSE, 31.19) is having a rough time, with several of its holdings severely hit by not only Covid restrictions but by broader market conditions as well. Its struggling, majority-owned Diamond Offshore succumbed to weak oil markets by filing for bankru...
Streetwise Reports | May 29, 2020 |

Solutions for the temperature-induced challenges for Integrated Circuits

Author: Mansour KhatibAn Electro-Thermal aware design environment system is the best solution for detecting thermal flaws and weaknesses to ensure reliable, high-performance integrated circuits....
Research | September 29, 2022 |

Biotech's DMD Therapeutic 'Solidifies the Ground for Potential Pivotal Design'

The latest development concerning this clinical asset and other Q2/19 highlights are provided in an H.C. Wainwright & Co. report. In an Aug. 8 research note, analyst Joseph Pantginis reviewed Capricor Therapeutics Inc.'s (CAPR:NASDAQ) Q2/19 financials and reported t...
Streetwise Reports | August 14, 2019 |

Co-Diagnostics Utilizes CoPrimer Platform to Design New Coronavirus Detection Test

Molecular diagnostics company Co-Diagnostics' shares opened more than 144% higher after the firm reported it has designed a test for virus detection of the new coronavirus, 2019-nCoV, using its CoPrimer™ platform. In the wake of widespread news and worldwide concerns ...
Streetwise Reports | January 24, 2020 |

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

We are initiating coverage on INmune Bio Inc. (INMB:NASDAQ) . According to the company, INmune is "Reprogramming the Innate Immune System for the Treatment of Diseases." On the surface, this sounds like a fairly standard biotech tagline, but there's a more here than me...
Streetwise Reports | December 5, 2019 |

Correction in Gold Stocks Continues

Several weeks ago both Gold and gold stocks hit major resistance after strong but extended moves. A correction or pause was to be expected. Clearly, we can now say, the sector is in correction mode. Corrections tend to have three legs: a simple down up down or A-B-C patter...
Jordan Roy-Byrne, CMT | October 1, 2019 |
1 2 3 4 5 6 7 8 9 10 ...